PYC Therapeutics (Australia) Analysis
| PYC Stock | 1.40 0.05 3.45% |
PYC Therapeutics is overvalued with Real Value of 1.31 and Hype Value of 1.4. The main objective of PYC Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what PYC Therapeutics is worth, separate from its market price. There are two main types of PYC Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect PYC Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of PYC Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The PYC Therapeutics stock is traded in Australia on Australian Securities Exchange, with the market opening at 09:50:00 and closing at 16:12:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Australia. PYC Therapeutics is usually not traded on Christmas Day, Boxing Day, New Year 's Day, Australia Day, Australia Day ( substitute day ), Good Friday, Easter Monday, ANZAC Day. PYC Stock trading window is adjusted to Australia/Sydney timezone.
PYC |
PYC Stock Analysis Notes
About 59.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.1. PYC Therapeutics had not issued any dividends in recent years. The entity had 1:10 split on the 15th of November 2024. To find out more about PYC Therapeutics contact GDLP JD at 61 8 6151 0992 or learn more at https://pyctx.com.PYC Therapeutics Investment Alerts
| PYC Therapeutics generated a negative expected return over the last 90 days | |
| PYC Therapeutics may become a speculative penny stock | |
| PYC Therapeutics has high historical volatility and very poor performance | |
| PYC Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 22.06 M. Net Loss for the year was (37.73 M) with profit before overhead, payroll, taxes, and interest of 15.81 M. | |
| PYC Therapeutics has accumulated about 15.57 M in cash with (38.59 M) of positive cash flow from operations. | |
| Roughly 59.0% of the company outstanding shares are owned by corporate insiders |
PYC Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 653.25 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PYC Therapeutics's market, we take the total number of its shares issued and multiply it by PYC Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.PYC Profitablity
PYC Therapeutics' profitability indicators refer to fundamental financial ratios that showcase PYC Therapeutics' ability to generate income relative to its revenue or operating costs. If, let's say, PYC Therapeutics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, PYC Therapeutics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of PYC Therapeutics' profitability requires more research than a typical breakdown of PYC Therapeutics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.71) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.78) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.78. Management Efficiency
PYC Therapeutics has return on total asset (ROA) of (0.3783) % which means that it has lost $0.3783 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6961) %, meaning that it generated substantial loss on money invested by shareholders. PYC Therapeutics' management efficiency ratios could be used to measure how well PYC Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Total Current Liabilities is likely to gain to about 9.6 M in 2024. Liabilities And Stockholders Equity is likely to gain to about 95.8 M in 2024Leadership effectiveness at PYC Therapeutics is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin (1.78) | Profit Margin (1.71) | Beta 0.601 | Return On Assets (0.38) | Return On Equity (0.70) |
Technical Drivers
As of the 25th of December, PYC Therapeutics owns the market risk adjusted performance of 0.1481, and Coefficient Of Variation of (30,306). In relation to fundamental indicators, the technical analysis model allows you to check practical technical drivers of PYC Therapeutics, as well as the relationship between them.PYC Therapeutics Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. PYC Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for PYC Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
PYC Therapeutics Outstanding Bonds
PYC Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PYC Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PYC bonds can be classified according to their maturity, which is the date when PYC Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
PYC Therapeutics Predictive Daily Indicators
PYC Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of PYC Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 22808.33 | |||
| Daily Balance Of Power | (0.71) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 1.44 | |||
| Day Typical Price | 1.42 | |||
| Price Action Indicator | (0.06) | |||
| Period Momentum Indicator | (0.05) |
PYC Therapeutics Forecast Models
PYC Therapeutics' time-series forecasting models are one of many PYC Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PYC Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About PYC Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how PYC Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PYC shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as PYC Therapeutics. By using and applying PYC Stock analysis, traders can create a robust methodology for identifying PYC entry and exit points for their positions.
PYC Therapeutics is entity of Australia. It is traded as Stock on AU exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding PYC Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
Additional Tools for PYC Stock Analysis
When running PYC Therapeutics' price analysis, check to measure PYC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PYC Therapeutics is operating at the current time. Most of PYC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PYC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PYC Therapeutics' price. Additionally, you may evaluate how the addition of PYC Therapeutics to your portfolios can decrease your overall portfolio volatility.